Companies

PUMA BIOTECHNOLOGY, INC. (PBYI) SEC filings

CIK 0001401667 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024FY2022FY2021
Revenue (USD)228.4 M228.0 M
Net income (USD)-60.0 M-75.6 M
Diluted EPS (USD/shares)0.610

Latest filings

FiledFormDescriptionPeriod
2026-10-06SCHEDULE 13D/ASCHEDULE 13D/A
2026-09-164FORM 42026-09-14
2026-09-164FORM 42026-09-14
2026-09-14144144
2026-09-14144144
2026-08-0610-QFORM 10-Q2026-06-30
2026-08-068-KFORM 8-K items 2.02,9.012026-08-06
2026-07-084FORM 42026-07-06
2026-07-084FORM 42026-07-06
2026-07-084FORM 42026-07-06
2026-07-06144144
2026-07-06144144
2026-07-06144144
2026-06-168-KFORM 8-K items 5.072026-06-11
2026-06-154FORM 42026-06-11
2026-06-154FORM 42026-06-11
2026-06-154FORM 42026-06-11
2026-06-154FORM 42026-06-11
2026-06-154FORM 42026-06-11
2026-06-154FORM 42026-06-11
2026-06-154FORM 42026-06-11
2026-06-12144144
2026-06-12144144
2026-06-12144144
2026-06-12144144

Forms on file (last 1,000): 4 414, 8-K 192, SC 13G/A 70, 144 67, 10-Q 42, SC 13G 35, DEFA14A 23, 3 16. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=PBYI (0.002 USD), /gw/filings/filings?ticker=PBYI&form=8-K, /gw/filings/facts?ticker=PBYI&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange